Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers

Documenti analoghi

• Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios
  di: Kenza Abouir, et al.
  Pubblicazione: (2024)
• Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation
  di: Hyun Woong Park, et al.
  Pubblicazione: (2025)
• Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers
  di: Tomoki Koishikawa, et al.
  Pubblicazione: (2024)
• Physiologically Based Pharmacokinetic Modeling to Investigate the Disease‐Drug–Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID‐19 Patients with CYP2C19 Phenotypes
  di: Peile Wang, et al.
  Pubblicazione: (2024)
• A Comprehensive CYP2D6 Drug–Drug–Gene Interaction Network for Application in Precision Dosing and Drug Development
  di: Simeon Rüdesheim, et al.
  Pubblicazione: (2025)